142 related articles for article (PubMed ID: 1647477)
1. Magnetic resonance imaging (MRI) and pathophysiology of the rat kidney in streptozotocin-induced diabetes.
Lohr J; Mazurchuk RJ; Acara MA; Nickerson PA; Fiel RJ
Magn Reson Imaging; 1991; 9(1):93-100. PubMed ID: 1647477
[TBL] [Abstract][Full Text] [Related]
2. In vivo NMR imaging and spectroscopic investigation of renal pathology in lean and obese rat kidneys.
Bosch CS; Ackerman JJ; Tilton RG; Shalwitz RA
Magn Reson Med; 1993 Mar; 29(3):335-44. PubMed ID: 8450742
[TBL] [Abstract][Full Text] [Related]
3. Relationship between MRI and morphometric kidney measurements in diabetic and non-diabetic rats.
Christiansen T; Rasch R; Stødkilde-Jørgensen H; Flyvbjerg A
Kidney Int; 1997 Jan; 51(1):50-6. PubMed ID: 8995717
[TBL] [Abstract][Full Text] [Related]
4. Development of renal hypertrophy and increased renal Na,K-ATPase in streptozotocin-diabetic rats.
Ku DD; Sellers BM; Meezan E
Endocrinology; 1986 Aug; 119(2):672-9. PubMed ID: 3015553
[TBL] [Abstract][Full Text] [Related]
5. Duration of streptozotocin-induced diabetes differentially affects p38-mitogen-activated protein kinase (MAPK) phosphorylation in renal and vascular dysfunction.
Chen H; Brahmbhatt S; Gupta A; Sharma AC
Cardiovasc Diabetol; 2005 Mar; 4():3. PubMed ID: 15748291
[TBL] [Abstract][Full Text] [Related]
6. Age of onset of streptozocin diabetes determines the renal structural response in the rat.
Lane PH
Pediatr Res; 1997 Jun; 41(6):912-5. PubMed ID: 9167208
[TBL] [Abstract][Full Text] [Related]
7. Reduced oxygenation in diabetic rat kidneys measured by T2* weighted magnetic resonance micro-imaging.
Edlund J; Hansell P; Fasching A; Liss P; Weis J; Glickson JD; Palm F
Adv Exp Med Biol; 2009; 645():199-204. PubMed ID: 19227472
[TBL] [Abstract][Full Text] [Related]
8. Loss of kidney IGF-1 receptors in experimental long-term diabetic rats.
Obineche EN; Mensah-Brown E; Chandranath SI; Arafar K; Adem A
Endocr Res; 2001 Aug; 27(3):293-302. PubMed ID: 11678576
[TBL] [Abstract][Full Text] [Related]
9. Effect of lanreotide on local kidney IGF-I and renal growth in experimental diabetes in the rat.
Grønbaek H; Nielsen B; Frystyk J; Flyvbjerg A; Orskov H
Exp Nephrol; 1996; 4(5):295-303. PubMed ID: 8931985
[TBL] [Abstract][Full Text] [Related]
10. Connective tissue growth factor is associated with the early renal hypertrophy in uninephrectomized diabetic rats.
Liu BC; Huang HQ; Luo DD; Ma KL; Liu DG; Liu H
Chin Med J (Engl); 2006 Jun; 119(12):1010-6. PubMed ID: 16805985
[TBL] [Abstract][Full Text] [Related]
11. Detection of evolving acute tubular necrosis with renal 23Na MRI: studies in rats.
Maril N; Margalit R; Rosen S; Heyman SN; Degani H
Kidney Int; 2006 Feb; 69(4):765-8. PubMed ID: 16518333
[TBL] [Abstract][Full Text] [Related]
12. Assessment of impaired vascular reactivity in a rat model of diabetic nephropathy: effect of nitric oxide synthesis inhibition on intrarenal diffusion and oxygenation measured by magnetic resonance imaging.
Hueper K; Hartung D; Gutberlet M; Gueler F; Sann H; Husen B; Wacker F; Reiche D
Am J Physiol Renal Physiol; 2013 Nov; 305(10):F1428-35. PubMed ID: 24005471
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of dendroaspis natriuretic peptide and its receptor in streptozotocin-induced diabetic rats.
Park BH; Kim SY; Kim SM; Noh HJ; Cho CG; Kim SZ
Mol Med Rep; 2015 Aug; 12(2):2969-76. PubMed ID: 25937111
[TBL] [Abstract][Full Text] [Related]
14. Morphological changes in the rat kidney following long-term diabetes.
Obineche EN; Mensah-Brown E; Chandranath SI; Ahmed I; Naseer O; Adem A
Arch Physiol Biochem; 2001 Jul; 109(3):241-5. PubMed ID: 11880928
[TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance microscopy of toxic renal injury induced by bromoethylamine in rats.
Hedlund LW; Maronpot RR; Johnson GA; Cofer GP; Mills GI; Wheeler CT
Fundam Appl Toxicol; 1991 May; 16(4):787-97. PubMed ID: 1884916
[TBL] [Abstract][Full Text] [Related]
16. Differential regulation of angiotensin II receptors during renal injury and compensatory hypertrophy in the rat.
Joly E; Nonclercq D; Caron N; Mertens J; Flamion B; Toubeau G; Kramp R; Bouby N
Clin Exp Pharmacol Physiol; 2005 Apr; 32(4):241-8. PubMed ID: 15810986
[TBL] [Abstract][Full Text] [Related]
17. Regression of renal hypertrophy and elevated renal Na+,K+-ATPase activity after insulin treatment in streptozotocin-diabetic rats.
Ku DD; Roberts RB; Sellers BM; Meezan E
Endocrinology; 1987 May; 120(5):2166-73. PubMed ID: 3032576
[TBL] [Abstract][Full Text] [Related]
18. Somatostatin analogue administration prevents increase in kidney somatomedin C and initial renal growth in diabetic and uninephrectomized rats.
Flyvbjerg A; Frystyk J; Thorlacius-Ussing O; Orskov H
Diabetologia; 1989 Apr; 32(4):261-5. PubMed ID: 2759363
[TBL] [Abstract][Full Text] [Related]
19. Renal enlargement: comparative autoradiographic studies of 3H-thymidine uptake in diabetic and uninephrectomized rats.
Rasch R; Nörgaard JO
Diabetologia; 1983 Sep; 25(3):280-7. PubMed ID: 6642092
[TBL] [Abstract][Full Text] [Related]
20. Renal hypertrophy in experimental diabetes. A morphometric study.
Seyer-Hansen K; Hansen J; Gundersen HJ
Diabetologia; 1980 Jun; 18(6):501-5. PubMed ID: 7418959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
